Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Higher doses of cranial irradiation are linked to permanent hair loss.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Pegvaliase is recommended for treating adults with phenylketonuria.

Some common medications can harm male fertility, but many effects can be reversed.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.